跳至主要内容
临床试验/JPRN-UMIN000050332
JPRN-UMIN000050332尚未招募Unknown

Effectiveness of smartphone application "Fukusuppo App" to support head and neck cancer patients in the management of toxicities associated with immnue checkpoint inhibitor: a prospective observation study - Fukusuppo study

ational Cancer Center Hospital East0 个研究点目标入组 68 人开始时间: 2023年3月6日最近更新:
适应症

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) The primary site of tumor is thyroid. 2) Patient has a history of immune checkpoint inhibitors including other types of cancer. 3) Patient is planned to be treated with both immune checkpoint inhibitors and chemotherapy. 4) The patient's physician determines that the patient is not suitable to participate in this study.

研究者

发起方
ational Cancer Center Hospital East

相似试验